Non-Insulin Therapies For Diabetes Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theNon-Insulin Therapies For Diabetes Market?
Increasing diabetes prevalence is projected to support the non-insulin therapies for diabetes market. Contributing factors include sedentary habits, poor nutrition, aging, and lack of healthcare access. Non-insulin therapies enhance glycemic control and glucose metabolism. In April 2023, The British Diabetic Association reported 4.3 million diagnosed diabetes cases in the UK, a rise of 148,951 from the previous year. The growing need for alternatives boosts this market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16494&type=smp
#What is the Growth Potential of the Non-Insulin Therapies For Diabetes Market, and How Will It Perform by 2034?
The non-insulin therapies for diabetes market has increased from $19.98 billion in 2024 to $21.41 billion in 2025 at a CAGR of 7.1%. Contributing factors were a rise in diabetes cases, better awareness, increased healthcare spending, lifestyle changes, higher diagnosis rates, government initiatives, and pharmaceutical R&D investments.
The non-insulin therapies for diabetes market is expected to grow strongly, reaching $27.9 billion by 2029 at a CAGR of 6.8%. Growth is supported by rising diabetes prevalence, awareness of diabetes management, combination therapy adoption, expanding geriatric populations, increasing healthcare spending, telemedicine expansion, and a preference for oral medications. Key trends include advancements in oral and injectable medications, drug delivery systems, oral peptide delivery, telemedicine integration, and combination therapy advancements.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16494
Which Cutting-Edge Market Trends Are Expected to Drive theNon-Insulin Therapies For Diabetes Market’s Growth?
Companies in the non-insulin therapies for diabetes market are introducing personalized management systems to optimize treatment through real-time monitoring and data insights. In November 2022, Eli Lilly and Company, a US pharmaceutical giant, launched the Tempo platform comprising a Smart Button, TempoSmart app, and prefilled Tempo Pen to support informed decision-making in diabetes care.
What Are the Leading Market Players Impacting theNon-Insulin Therapies For Diabetes Market’s Growth Trend?
Major companies operating in the non-insulin therapies for diabetes market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi, The Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Les Servier Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Uni-Bio Science Group Ltd., Intarcia Therapeutics, Janssen Pharmaceuticals, Boan Biotech, SatRx LLC
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Non-Insulin Therapies For Diabetes Market Driving Opportunities and Innovations?
The non-insulin therapies for diabetes market covered in this report is segmented –
1) By Drug Class: Biguanides, Sulfonylureas, Thiazolidinedione’s, Alpha-Glucosidase Inhibitors, Dipeptidyl peptidase-4 (DPP-4) Inhibitors, Glucagon-like peptide-1 (GLP-1) Analogs, Sodium-glucose co-transporter-2 (SGLT2) Inhibitors
2) By Route Of Administration: Oral, Intramuscular
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy
4) By Application: Monitoring, Diagnosis, Treatment, Other Applications
Subsegments:
1) By Biguanides: Metformin, Combination Of Metformin With Other Drugs
2) By Sulfonylureas: Glimepiride, Glipizide, Glyburide
3) By Thiazolidinediones: Pioglitazone, Rosiglitazone
4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
5) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
6) By Glucagon-Like Peptide-1 (GLP-1) Analogs: Exenatide, Liraglutide, Dulaglutide, Semaglutide
7) By Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16494&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theNon-Insulin Therapies For Diabetes Market?# Market Expansion?
North America was the largest region in the non-insulin therapies for diabetes market in 2024. The regions covered in the non-insulin therapies for diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Non-Insulin Therapies For Diabetes Market 2025, By The Business Research Company:
Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024
Insulin Patch Pumps Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report
Insulin biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
